Comparison of ε-Aminocaproic Acid and Tranexamic Acid in Reducing Postoperative Transfusions in Total Hip Arthroplasty

Journal of Arthroplasty

Volumn 31, Issue 12, 2016, Pages 2795-2799.e1

  Churchill, Jessica L ^a   Puca, Kathleen E ^b   Meyer, Elizabeth S ^c   Carleton, Matthew C ^d   Truchan, Susan L ^e   Anderson, Michael J ^e  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b BLOOD RESEARCH INSTITUTE   (United States)

^c ST LUKE S MEDICAL CENTER   (United States)

^d Aurora West Allis Medical Center   (United States)

^e Advanced Healthcare   (United States)

Author keywords

antifibrinolytic therapy; blood conservation; total hip arthroplasty; tranexamic acid; transfusion; aminocaproic acid

Indexed keywords

AMINOCAPROIC ACID; HEMOGLOBIN; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; ERYTHROCYTE TRANSFUSION; FEMALE; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDY; TOTAL HIP PROSTHESIS; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; COMPARATIVE STUDY; HIP REPLACEMENT; MIDDLE AGED; STATISTICS AND NUMERICAL DATA;

AGED; AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; ERYTHROCYTE TRANSFUSION; FEMALE; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES; TRANEXAMIC ACID;

EID: 84973535594     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2016.05.011     Document Type: Article

References (26)

1. 1 Birrell, F., Johnell, O., Silman, A., Projecting the need for hip replacement over the next three decades: influence of changing demography and threshold for surgery. Ann Rheum Dis, 58(9), 1999, 569.
2. 2 Kurtz, S., Mowat, F., Ong, K., et al. Prevalence of primary and revision total hip and knee arthroplasty in the United States from 1990 through 2002. J Bone Joint Surg Am, 87(7), 2005, 1487.
3. 3 Lanes, S.F., Lanza, L.L., Radensky, P.W., et al. Resource utilization and cost of care for rheumatoid arthritis and osteoarthritis in a managed care setting: the importance of drug and surgery costs. Arthritis Rheum, 40(8), 1997, 1475.
4. 4 Jans, O., Kehlet, H., Hussain, Z., et al. Transfusion practice in hip arthroplasty—a nationwide study. Vox Sang, 100(4), 2011, 374.
5. 5 Bierbaum, B.E., Callaghan, J.J., Galante, J.O., et al. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am, 81(1), 1999, 2.
6. 6 Browne, J.A., Adib, F., Brown, T.E., et al. Transfusion rates are increasing following total hip arthroplasty: risk factors and outcomes. J Arthroplasty, 28(8 Suppl), 2013, 34.
7. 7 Chen, A.F., Klatt, B.A., Yazer, M.H., et al. Blood utilization after primary total joint arthroplasty in a large hospital network. HSS J, 9, 2013, 123.
8. 8 Friedman, R., Homering, M., Holberg, G., et al. Allogeneic blood transfusion and postoperative infections after total hip or knee arthroplasty. J Bone Joint Surg Am, 96, 2014, 272.
9. 9 Vamvakas, E.C., Blajchman, M.A., Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood, 113(15), 2009, 3406.
10. 10 Shander, A., Hofmann, A., Ozawa, S., et al. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion, 50(4), 2010, 753.
11. 11 Gillette, B.P., Maradit Kremers, H., Duncan, C.M., et al. Economic impact of tranexamic acid in healthy patients undergoing primary total hip and knee arthroplasty. J Arthoplasty, 28(8Suppl), 2013, 137.
12. 12 Henry, D.A., Carless, P.A., Moxey, A.J., et al. Anti-fibrinolytic use for minimizing perioperative allogeneic blood transfusion. Cochrane Database Syst Rev, 3, 2011, CD001886.
13. 13 Huang, F., Yunfeng, W., Zongsheng, Y., et al. A systematic review and meta-analysis of the use of antifbirinolytic agents in total hip arthroplasty. Hip Int, 25(6), 2015, 502.
14. 14 Tranexamic acid. Lexi-Drugs. Lexicomp. Wolters Kluwer Health, Inc. Hudson, OH, http://on-line.lexi.com [accessed 14.12.15].
15. 15 Aminocaproic acid. Lexi-Drugs. Lexicomp. Wolters Kluwer Health, Inc. Hudson, OH, http://on-line.lexi.com [accessed 14.12.15].
16. 16 Falana, O., Patel, G., Efficacy and safety of tranexamic acid versus ε-aminocaproic acid in cardiovascular surgery. Ann Pharmacother, 48(12), 2014, 1563.
17. 17 Raghunathan, K., Connelly, N.R., Kanter, G.J., ε-aminocaproic acid and clinical value in cardiac anesthesia. J Cardiothorac Vasc Anesth, 25(1), 2011, 16.
18. 18 3M HIS APRTM-DRG Classification Software—Overview, http://archive.ahrq.gov/professionals/quality-patient-safety/quality-resources/tools/mortality/Hughessumm.pdf [accessed 05.12.15].
19. 19 Keating, E.M., Meding, J.B., Perioperative blood management practices in elective orthopedic surgery. J Am Acad Orthop Surg, 10(6), 2002, 393.
20. 20 Nadeau, R.P., Howard, J.L., Naudie, D.D.R., Antifibrinolytic therapy for perioperative blood conservation in lower-extremity primary total joint arthroplasty. JBJS Rev, 3(6), 2015, e1.
21. 21 Ray, M., Hatcher, S., Whitehouse, S.L., et al. Aprotinin and epsilon amniocaproic acid are effective in reducing blood loss after primary total hip arthroplasty—a prospective randomized double-blind placebo-controlled study. J Thromb Haemost, 3, 2005, 1421.
22. 22 Harley, B.J., Beaupre, L.A., Jones, A., et al. The effect of epsilon aminocaproic acid on blood loss in patients who undergo primary total hip replacement: a pilot study. Can J Surg, 45(3), 2002, 185.
23. 23 Camarasa, M.A., Olle, G., Serra-Prat, M., et al. Efficacy of aminocaproic, tranexamic acids in the control of bleeding during total knee replacement: a randomized clinical trial. Br J Anaesth, 96, 2006, 576.
24. 24 Makhija, N., Sarupria, A., Kumar Choudhary, S., et al. Comparison of epsilon aminocaproic acid and tranexamic acid in thoracic aortic surgery: clinical efficacy and safety. J Cardiothorac Vasc Anesth, 27(6), 2013, 1201.
25. 25 Peters, A., Verma, K., Slobodyanyuk, K., et al. Antifibrinolytics reduce blood loss in adult spinal deformity surgery: a prospective, randomized controlled trial. Spine, 40(8), 2015, 443.
26. 26 Seymour, B.D., Rubinger, M., Rhabdomyolysis induced by epsilon-aminocaproic acid. Ann Pharmacother, 31(1), 1997, 56.